Evidence map›Paper›PMID 34866990›Full record

ReviewSaudi journal of biological sciences2021

Genus Ziziphus for the treatment of chronic inflammatory diseases.

Abdulrhman Alsayari, Shadma Wahab

Open access · hybridAbstract readReview
In one paragraph

Review in Saudi journal of biological sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. LC-DAD-MSChemistry & biodiversity · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Plants (Basel, Switzerland) · 2024
    Article
  13. Potential Pharmacological Applications ofPlants (Basel, Switzerland) · 2023
    Review
  14. Genotyping of Jujube (Plants (Basel, Switzerland) · 2023
    Article
  15. Isolation and identification of novel selective antitumor constituents, sidrin and sidroside, fromSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Article
  16. Article
  17. Optimizing the Fermentation Conditions ofEvidence-based complementary and alternative medicine : eCAM · 2023
    Article
  18. Article
  19. Review
  20. Pharmacological and Clinical Efficacy ofMolecules (Basel, Switzerland) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Abdulrhman AlsayariDepartment of Pharmacognosy, College of Pharmacy, King Khalid University, Abha 61421, Saudi Arabia.
Shadma WahabDepartment of Pharmacognosy, College of Pharmacy, King Khalid University, Abha 61421, Saudi Arabia.
King Khalid University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural products and traditional medicine are rich sources for developing therapeutics for chronic inflammatory diseases. However, the way from natural products/traditional medicines to Western pharmaceutical practices is not always straightforward. According to the World Health Organization (WHO), chronic diseases are the greatest threat to human health. 3 of 5 people die due to chronic inflammatory disorders worldwide like chronic respiratory diseases, stroke, cardiovascular diseases, cancer, diabetes, and obesity. Various nonsteroidal anti-inflammatory drugs (NSAIDs) are used to reduce inflammation and pain, but there are many side effects of these drugs' administration. Medicinal plants have therapeutic anti-inflammatory effects with low or no side effects.

Indexed as

AnticancerAntidiabeticCardiovascular diseaseChronic inflammatory diseasesNeurological disorderZiziphus

Identifiers

PMID34866990
PMCPMC8626254
OpenAlexW3187305460

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.